FREESTYLE LIBRE HONORED BY PRIX GALIEN

Continuous glucose monitor named Best Medical Technology as part of Galien Foundation’s Prix Galien competition.

FreeStyle Libre Honored by Prix Galien

Oct 25 2019

Abbott's revolutionary FreeStyle Libre continuous glucose monitoring system (including the FreeStyle Libre 14 day system) was named Thursday as the Best Medical Technology by the Galien Foundation as part of the non-profit's Prix Galien USA competition, the equivalent of the Nobel Prize in biopharmaceutical research.

The Prix Galien culminates each year with its awards across a range of categories from Best Pharmaceutical Agent to Best Biotechnology Product, and, in Abbott’s case, Best Medical Device or Diagnostic.

Simply stated, the foundation's mission is "to serve as a vehicle for the open exchange of ideas that drive science and new innovations."

The FreeStyle Libre 14 day system is just that kind of innovation. The recognition is a testament to our commitment to designing a technology that is accurate, affordable and accessible1 that truly changes millions of lives for people with diabetes.

Humans need sleep. Diabetes doesn't. It is a chronic — and potentially debilitating — condition that, if not managed properly, carries potential consequences that can be serious.

Nerve pain. Vision issues. Heart problems and circulation issues that can lead to amputation.

Unfortunately, many of the 425 million people worldwide and 30 million2 in the U.S. struggle to meet recommended treatment regimens. And it's understandable why, with round-the-clock glucose monitoring, crucial insulin treatment decisions, smart dietary and lifestyle choices as daily necessities.

Before FreeStyle Libre, traditional glucose monitoring hadn't changed for decades.

  • Prick a finger.
  • Drop of blood on a test strip.
  • Insert into a reader.
  • Wait.

Repeat dozens of times of day if you're on your game. In actuality, most people living with diabetes test, on average, 1.6 times daily3 due to these inconveniences and real pain from repeatedly making their fingers bleed.

In the U.S., FreeStyle Libre 14 Day system replaces the need for regular fingersticks, can be worn up to two weeks and is accurate for insulin dosing. With a wave over a sensor on the back of your upper arm, it offers real-time glucose readings, 8-hour historical trends and where those trends are heading.

Data from FreeStyle Libre 14 day can be shared with doctors and healthcare providers. Along with smart diabetes nutrition, you can devise the most effective treatment plan for their lives.

This isn't the first time the FreeStyle Libre 14 day system has been honored a trailblazing technology. Fast Company named it among the most innovative creations available.

Around the world, the FreeStyle Libre system is helping millions of people living with diabetes. It’s part of our commitment to creating life-changing technology that's helping people live their best lives. You can see more of how that tech came to be here.

For important safety information, please click here.

References:

1,2. Data on file.
3. Ong, W.M.; Chua, S.S.; Ng, C.J. (2014) Barriers and facilitators to self-monitoring of blood glucose in people with type 2 diabetes using insulin: a qualitative study. Patient Preference and Adherence, 8. pp. 237-246.
4. Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol, when symptoms do not match system readings, when you suspect readings may be inaccurate, or when you experience symptoms that may be due to high or low blood glucose.

 

true
accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.


The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?